-
1دورية أكاديمية
المؤلفون: Moein, AnitaAff1, Aff2, Jin, Jin Y., Wright, Matthew R., Wong, HarveyAff1, IDs00280024046904_cor4
المصدر: Cancer Chemotherapy and Pharmacology. :1-16
-
2دورية أكاديمية
المؤلفون: Goyal, Ravi K., Zhang, Jingchuan, Davis, Keith L., Sluga-O’Callaghan, Martina, Kaufman, Peter A.Aff3, IDs10549023070801_cor5
المصدر: Breast Cancer Research and Treatment. 205(1):201-210
-
3دورية أكاديمية
المؤلفون: Xin Peng, Xin Huang, Talal Ben Lulu, Wenqing Jia, Shaolu Zhang, Limor Cohen, Shengfan Huang, Jindian Fan, Xi Chen, Shanshan Liu, Yongzhe Wang, Kailin Wang, Sho Isoyama, Shingo Dan, Feng Wang, Zhe Zhang, Moshe Elkabets, Dexin Kong
المصدر: Molecular Cancer, Vol 23, Iss 1, Pp 1-23 (2024)
مصطلحات موضوعية: KTC1101, PI3K inhibitor, Tumor microenvironment, CD8+ T cells, Immunotherapy synergy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1476-4598
-
4دورية أكاديمية
المؤلفون: Kohei Nakamura, Marin Ishikawa, Ryutaro Kawano, Eriko Aimono, Takaaki Mizuno, Sachio Nohara, Shigeki Tanishima, Hideyuki Hayashi, Hiroshi Nishihara, The Keio PleSSision Group
المصدر: Cancer Medicine, Vol 13, Iss 14, Pp n/a-n/a (2024)
مصطلحات موضوعية: cis, multi‐PIK3CA mutations, PI3K inhibitor, precision oncology, trans, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2045-7634
-
5دورية أكاديمية
المؤلفون: Nadja Stiegeler, Dale W. Garsed, George Au-Yeung, David D. L. Bowtell, Viola Heinzelmann-Schwarz, Tibor A. Zwimpfer
المصدر: Frontiers in Oncology, Vol 14 (2024)
مصطلحات موضوعية: ovarian cancer, homologous recombination proficiency, treatment resistance, PARP inhibitor, CDK inhibitor, PI3K inhibitor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
6دورية أكاديمية
المؤلفون: Sanchit Duhan, Nadeem Tabbara, Bijeta Keisham, Nymisha Boddeti, Daniel A. Laheru
المصدر: Current Problems in Cancer: Case Reports, Vol 14, Iss , Pp 100294- (2024)
مصطلحات موضوعية: Alpelisib, PI3K inhibitor, PIK3K alpha inhibitor, HER-2 negative Breast cancer, Metastatic breast cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
7دورية أكاديمية
المؤلفون: Davoodi-Moghaddam, Zeinab, Jafari-Raddani, Farideh, Delshad, MahdaAff1, Aff2, Pourbagheri-Sigaroodi, Atieh, Bashash, DavoodAff1, IDs0043202305277x_cor5
المصدر: Journal of Cancer Research and Clinical Oncology. 149(16):15293-15310
-
8دورية أكاديمية
المؤلفون: Islam, PriotyAff1, IDs11864023011120_cor1
المصدر: Current Treatment Options in Oncology. 24(9):1259-1273
-
9دورية أكاديمية
المؤلفون: Yoo, Min-Jae, Choi, Jawun, Jang, Ye-ji, Park, Sang-Youel, Seol, Jae-WonAff1, IDs12917023037822_cor5
المصدر: BMC Veterinary Research. 19(1)
-
10دورية أكاديمية
المؤلفون: Hutchinson, Katherine E., Chen, Jessica W., Savage, Heidi M., Stout, Thomas J., Schimmoller, Frauke, Cortés, JavierAff3, Aff4, Dent, Susan, Harbeck, Nadia, Jacot, William, Krop, Ian, Trabucco, Sally E., Sivakumar, Smruthy, Sokol, Ethan S., Wilson, Timothy R.Aff1, IDs13073023011818_cor14
المصدر: Genome Medicine. 15(1)